Ensoma is a Biotech company based in Boston. It has raised $70M in total funding. Latest round: Series A.
Ensoma funding overview
Ensoma is a Biotech company based in Boston. Ensoma has raised $70M in total disclosed funding. That places its disclosed total in the $25M–$100M range. Its most recent disclosed round is a Series A announced in February 2021. The round record for Ensoma runs through 2021; nothing later has been disclosed. Investors on record include 5AM Ventures, F-Prime Capital, Takeda Ventures, Viking Global Investors, Cormorant Asset Management, RIT Capital Partners and 2 others. 8 distinct backers are named across the disclosed rounds.
Ensoma at a glance
Total raised
$70M
Latest round
Series A
Latest round date
February 2021
Industry
Biotech
Headquarters
Boston
Notable investors
5AM Ventures, F-Prime Capital, Takeda Ventures, Viking Global Investors, Cormorant Asset Management, RIT Capital Partners, Symbiosis II, LLC, Alexandria Venture Investments
Frequently asked about Ensoma funding
How much has Ensoma raised?
Ensoma has raised $70M in total disclosed funding across the rounds on record.
Who has invested in Ensoma?
5AM Ventures, F-Prime Capital, Takeda Ventures, Viking Global Investors, Cormorant Asset Management, RIT Capital Partners are named among the investors backing Ensoma.
What was the latest Ensoma funding round?
The most recent disclosed round is a Series A, announced in February 2021.
Where is Ensoma based?
Ensoma is based in Boston.
What sector does Ensoma operate in?
Ensoma is tracked under Biotech from Boston, with $70M in disclosed funding.
When did Ensoma last raise?
The last disclosed Ensoma round closed in February 2021 at Series A.
Every Ensoma figure above comes from filings and announced rounds in the StartupFundraising company database and is revised as new rounds are recorded. The lists below compare Biotech companies in Boston at a similar stage.
